Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Biocryst Pharmaceuticals (DE:BO1)
FRANKFURT:BO1
Holding DE:BO1?
Track your performance easily
BioCryst (BO1) Ownership Overview
6.34% Insiders
16.93% Mutual Funds
0.19% Other Institutional Investors
16.69% ETFs
59.84% Public Companies and
Individual Investors
The ownership structure of BioCryst (DE:BO1) stock is a mix of institutional, retail, and individual investors. Approximately 33.82% of the company’s stock is owned by Institutional Investors, 6.34% is owned by Insiders, and 59.84% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Jun 25, 2024 | Amy E Mckee Director | xxxxxxxxxxxxx | $54352 |
| Jun 17, 2024 | Machelle Sanders Director | xxxxxxxxxxxxx | $28134 |
| Jun 14, 2024 | Theresa Heggie Director | xxxxxxxxxxxxx | $40925 |
| May 31, 2024 | Alan Levin Director | xxxxxxxxxxxxx | $49996 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Jun 30, 2024 | xxxxxxxxxxxxx | $468308 | |
| Jun 30, 2024 | xxxxxxxxxxxxx | $17654424 | |
| Jun 30, 2024 | xxxxxxxxxxxxx | $50279268 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 15,583,769 | Institution | 7.53% | 114,618,621 | |
| 13,678,320 | Institution | 6.61% | 100,604,044 | |
| 10,204,089 | Insider | 4.98% | 75,051,075 | |
| 10,096,812 | Institution | 4.88% | 74,262,052 | |
| 8,135,804 | Institution | 3.93% | 59,838,838 | |
| 4,360,105 | Institution | 2.11% | 32,068,572 | |
| 4,306,457 | Institution | 2.08% | 31,673,991 | |
| 2,856,703 | Institution | 1.38% | 21,011,051 | |
| 2,314,582 | Institution | 1.12% | 17,023,751 | |
| 2,080,313 | Institution | 1.01% | 15,300,702 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 13,678,320 | Institution | 6.61% | 100,604,044 | |
| 4,360,105 | Institution | 2.11% | 32,068,572 | |
| 2,314,582 | Institution | 1.12% | 17,023,751 | |
| 2,080,313 | Institution | 1.01% | 15,300,702 | |
| 1,787,181 | Institution | 0.86% | 13,144,716 | |
| 1,269,343 | Institution | 0.61% | 9,336,018 | |
| 1,215,893 | Institution | 0.59% | 8,942,893 | |
| 882,846 | Institution | 0.43% | 6,493,332 | |
| 788,652 | Institution | 0.38% | 5,800,535 | |
| 692,409 | Institution | 0.33% | 5,092,668 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns Biocryst Pharmaceuticals (DE:BO1)?
According to the latest TipRanks data, approximately 0.19% of the company's stock is held by institutional investors, 6.34% is held by insiders, and 59.84% is held by retail investors.
What percentage of Biocryst Pharmaceuticals (DE:BO1) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.19% of Biocryst Pharmaceuticals (DE:BO1) stock is held by institutional investors.
What percentage of Biocryst Pharmaceuticals (DE:BO1) stock is held by retail investors?
According to the latest TipRanks data, approximately 59.84% of Biocryst Pharmaceuticals (DE:BO1) stock is held by retail investors.
Who owns the most shares of Biocryst Pharmaceuticals (DE:BO1)?
Vanguard owns the most shares of Biocryst Pharmaceuticals (DE:BO1).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.